Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
about
Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain.Unmasking the mysteries of the habenula in pain and analgesia.Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain.Factors associated with tender point count in Puerto Ricans with fibromyalgia syndromeDuloxetine in panic disorder with somatic gastric pain.Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement.
P2860
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
@ast
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
@en
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
@nl
type
label
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
@ast
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
@en
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
@nl
prefLabel
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
@ast
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
@en
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
@nl
P2093
P2860
P356
P1476
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
@en
P2093
Alan Wright
Chad Vandenberg
Kyle E Luedtke
P2860
P356
10.2147/JPR.S12866
P577
2010-12-16T00:00:00Z